Total Funding
18
Total FundingSeries A raised
Growth Score in past quarter
pts
Heat Score 18 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
24236
Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.
David Guyer: Co-Founder and CEOPast Role: Eyetech Pharmaceuticals, Co-Founder and CEO- Anthony P. Adamis: Co-FounderPast Role: Eyetech Pharmaceuticals, CSO

Merck
About the Company
Eyebiotech is a vision treatment company that develops products to preserve, repair, and improve eyesight. The firm guards against sight-threatening eye disorders and developed the first anti-vascular endothelial growth factor medication for patients with age-related macular degeneration, allowing those with eye ailments to regain their eyesight.